Tag: ibb
Biotech Sector Getting Back on the Bullish Track
This article is a collaboration between between Arun Chopra (@FusionPtCapital) and Aaron Jackson (@ATMcharts).
Biotech had a banner week, leading the market after a base breakout on news. Let’s dig...
DeMark Indicators Could Spell Trouble For Biotech Stocks
Biotech stocks and the Biotech Sector have been a volatile space for investors this year. One month they are rallying, the next they are...
Compression Signal Says Biotech Stocks Poised For Huge Move
“Timing the market is a fool’s game.” We hear this all the time. However, the notion that markets are efficient is a fallacy. Markets...
Biotech ETF (XBI) On The Brink Of A Breakout
The volatility in the biotech space over the last two years has been quite a sight to behold.
I’m not strictly speaking of volatility in...
Biotech Sector (IBB): A Closer Look At The 2017 Rally
The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing.
On Wednesday, it finished off by -2.99%.
While that...
Biotech Sector (IBB): Is The Rally Just Getting Started?
Are we really talking about a biotech sector breakout? Biotech stocks have been through a lot in the last 12 months...
The biotech sector as...
Options Traders Look For Q2 Upside In Biotech Stocks
Biotech was a sector that was a notable laggard in Q1 with the Nasdaq Biotech Sector ETF (IBB) down nearly 24% and S&P Biotech...
Biotech Sector: A Breakout Would Be Huge For The Market
When it comes to leadership in the stock market, the Biotech sector has filled that role quite well during this bull market. And it...
Biotech Sector (IBB) Signals Downtrend Not Over
The S&P 500 has bounced nearly 8 percent over the last 8 trading days giving many investors hope for better days ahead. Perhaps a...
Market Outlook: Are Bond Bulls Ready To Run Higher?
In last week’s market outlook (“Stalemate“) I speculated about the potential danger of the market getting what it wanted from the Fed, namely no...